On the other hand, the expression levels of four major driver genes for pancreatic cancer (KRAS, CDKN2A, TP53, and SMAD4) [39] differed by less than 3-fold between the iF cells and the iTS-P cells in a microarray. This evidence concerns the gene CDKN2A and pancreatic neoplasm.